Tsart-M 40/25 Tablet ER
Marketer
Alkem Laboratories Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Tsart-M 40/25 Tablet ER
Cardiovasc-40/25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Prompt treatment improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician; don't discontinue it independently, even feeling well, as hypertension is often asymptomatic. Lifestyle modifications – regular exercise, weight management, and a balanced diet – complement this treatment. Adhere strictly to your doctor's instructions. Potential side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium, orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, and stomach pain. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any kidney or liver issues before starting this medication. Pregnant or lactating individuals should consult their physician before use. Always disclose all medications, especially those for hypertension or cardiac conditions.
Uses of Tsart-M 40/25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Tsart-M 40/25 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Tsart-M 40/25 Extended-Release Tablet should be administered with food.
Common Side effects of Tsart-M 40/25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Tsart-M 40/25 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Tsart-M 40/25 Tablet ER with a meal.
How Tsart-M 40/25 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Tsart-M 40/25 ER tablets, provide dual blood pressure control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Tsart-M 40/25 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tsart-M 40/25 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Tsart-M 40/25 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Tsart-M 40/25 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneySAFE IF PRESCRIBED
The extended-release Tsart-M 40/25 Tablet is considered safe for individuals with impaired renal function. No alteration of the Tsart-M 40/25 Tablet ER dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Tsart-M 40/25 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tsart-M 40/25 Tablet ER :
Should you forget to take a Tsart-M 40/25 Tablet ER, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tsart-M 40/25 Tablet ER
| Label | Value |
|---|---|
| Addictive | None. |
| Treatment Category | Heart-related |



